Experts highlight key data to help you prepare for what to expect at the upcoming breast cancer meeting in San Antonio. The CCO Conference Coverage program will feature downloadable slides and expert commentaries of clinically relevant studies presented at SABCS 2019. We will have the information you need to understand and integrate the latest data on optimizing breast cancer care into your practice.
Get insights from Sara Tolaney, MD, MPH, on key studies using chemotherapy-based regimens for HER2-negative and triple-negative breast cancer presented at the 2019 Breast Cancer meeting in San Antonio.
Get insights from Sara Hurvitz, MD, FACP, on key studies in HER2-positive breast cancer presented at the 2019 Breast Cancer meeting in San Antonio.
Get insights from Joyce O’Shaughnessy, MD, on key studies in HR-positive/HER2-negative breast cancer presented at the 2019 Breast Cancer meeting in San Antonio.
Review the most clinically relevant data presented at CTRC-AACR SABCS 2019 across multiple settings with this set of CME-certified expert commentaries, including advances in HER2-positive and hormone receptor–positive/HER2-negative disease, and in chemotherapy-based treatment strategies.
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.